Get started
Author

Antonio Carriero

Observed names: A Carriero, A. Carriero, ANTONIO CARRIERO, CARRIERO, Antonio, Carriero, Antonio
Institution: Ospedale San Carlo
Observed institutions: University of Foggia, University of Verona, University of Molise, University of Leeds, Leeds Teaching Hospitals NHS Trust, Azienda Ospedaliera Universitaria Integrata Verona, Ospedale San Carlo, NIHR Leeds Musculoskeletal Biomedical Research Unit, Ospedale Madonna Delle Grazie
ORCID: 0000-0002-3112-6488
Observed ORCID: 0000-0002-3112-6488
OpenAlex ID: A5064623067
Effectiveness and safety of secukinumab in 608 patients with psoriatic arthritis in real life: a 24-month prospective, multicentre study
2021 · Roberta Ramonda, Mariagrazia Lorenzin, et al. · RMD Open · 59
PDF
Targeting human plasmacytoid dendritic cells through BDCA2 prevents skin inflammation and fibrosis in a novel xenotransplant mouse model of scleroderma
2021 · Rebecca L. Ross, Clarissa Corinaldesi, et al. · Annals of the Rheumatic Diseases · 58
PDF
Nailfold capillaroscopic changes in patients with idiopathic pulmonary arterial hypertension and systemic sclerosis-related pulmonary arterial hypertension
2017 · A. Corrado, M. Correale, et al. · Microvascular Research · 56
Anti-IL-17 Agents in the Treatment of Axial Spondyloarthritis
2021 · Fabiola Atzeni, Antonio Carriero, et al. · ImmunoTargets and Therapy · 44
PDF
Large-Scale Postmarketing Surveillance of Biological Drugs for Immune-Mediated Inflammatory Diseases Through an Italian Distributed Multi-Database Healthcare Network: The VALORE Project
2021 · Gianluca Trifirò, Valentina Isgrò, et al. · BioDrugs · 42
Serum type I interferon score as a disease activity biomarker in patients with diffuse cutaneous systemic sclerosis: a retrospective cohort study
2025 · Monique Hinchcliff, Dinesh Khanna, et al. · The Lancet Rheumatology · 32
PDF
Golimumab effectiveness in biologic inadequate responding patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis in real-life from the Italian registry GISEA
2020 · Florenzo Iannone, Ennio G. Favalli, et al. · Joint Bone Spine · 22
Safety of treatment options for spondyloarthritis: a narrative review
2018 · Salvatore D’Angelo, Antonio Carriero, et al. · Expert Opinion on Drug Safety · 22
Effectiveness and safety of secukinumab in axial spondyloarthritis: a 24-month prospective, multicenter real-life study
2022 · Roberta Ramonda, Mariagrazia Lorenzin, et al. · Therapeutic Advances in Musculoskeletal Disease · 20
Four-year effectiveness, safety and drug retention rate of secukinumab in psoriatic arthritis: a real-life Italian multicenter cohort
2024 · Roberta Ramonda, Mariagrazia Lorenzin, et al. · Arthritis Research & Therapy · 15
PDF
Four-year real-world experience of secukinumab in a large Italian cohort of axial spondyloarthritis
2024 · Roberta Ramonda, Mariagrazia Lorenzin, et al. · Frontiers in Immunology · 12
IL-23 in axial spondyloarthritis and psoriatic arthritis: a good fit for biological treatment?
2022 · Fabiola Atzeni, Cesare Siragusano, et al. · Expert Opinion on Biological Therapy · 11
The Conundrum of Psoriatic Arthritis: a Pathogenetic and Clinical Pattern at the Midpoint of Autoinflammation and Autoimmunity
2022 · Rossana Scrivo, Salvatore D’Angelo, et al. · Clinical Reviews in Allergy & Immunology · 11
Recent Advances in Gut Microbiota in Psoriatic Arthritis
2025 · Maria Grazia Bonomo, Salvatore D’Angelo, et al. · Nutrients · 10
PDF
UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract (GIT) 2.0 Reflux Scale Correlates With Impaired Esophageal Scintigraphy Findings in Systemic Sclerosis
2021 · Giuseppina Abignano, Gianna Angela Mennillo, et al. · The Journal of Rheumatology · 10
PDF
Paradoxical psoriatic arthritis in a patient with psoriasis treated with guselkumab
2021 · Antonio Carriero, Ennio Lubrano, et al. · Clinical and Experimental Dermatology · 7
Understanding the Biological Significance of Anti-DFS70 Antibodies: Effect of Biologic Therapies on Their Occurrence in Inflammatory Arthritis
2020 · TERESA CARBONE, CARMELA ESPOSITO, et al. · The Journal of Rheumatology · 5
PDF
Thu0150 Interstitial Lung Disease Related to Rheumatoid Arthritis. What Do We Don't Know? the Lira Study (lung Involvement in Rheumatoid Arthritis).
2020 · M. Sebastiani, C. Vacchi, et al. · Annals of the Rheumatic Diseases · 4
PDF
Non-steroidal anti-inflammatory drugs in psoriatic arthritis: clinical practice suggestions based on scientific evidence and expert opinion.
2024 · Maria Manara, Antonio Carriero, et al. · Clinical and Experimental Rheumatology · 3
PDF
Corticosteroid injection treatment for dactylitis in psoriatic arthritis
2021 · Antonio Carriero, Ennio Lubrano, et al. · Therapeutic Advances in Musculoskeletal Disease · 3
PDF
231 Serum interferon score predicts clinical outcome at 12 months in diffuse cutaneous systemic sclerosis as measured by Global Ranked Composite Score (GRCS) and Composite Response Index in SSc (CRISS)
2019 · Antonio Carriero, Giuseppina Abignano, et al. · Rheumatology · 3
Interstitial lung involvement in rheumatoid arthritis patients treated with abatacept: a prospective observational study
2025 · Caterina Vacchi, Marco Sebastiani, et al. · Clinical and Experimental Rheumatology · 2
Sat0262 Modified Acr Composite Response Index in Systemic Sclerosis Score Shows Sensitivity and External Validation to Measure Magnitude of Response at 12 Months in Diffuse Cutaneous Systemic Sclerosis
2019 · Giuseppina Abignano, Antonio Carriero, et al. · Annals of the Rheumatic Diseases · 2
PDF
Pos0297 Effectiveness and Safety of Secukinumab in Axial Spondyloarthritis: a 24-month Prospective, Multicenter Real-life Study
2022 · G. Cozzi, M. Lorenzin, et al. · Annals of the Rheumatic Diseases · 1
PDF
Sat0281 Biosamples From at Risk Ssc Patients Show Classic Pathological Signs of Scleroderma: Opportunity for Diagnosis of Pre-clinical Ssc
2020 · R. Ross, I. Georgiou, et al. · Annals of the Rheumatic Diseases · 1
PDF
Works count: 44
Citation count: 459
H-index: 11
I10-index: 15
Year
Topic
Type